Related Experiment Videos
Telomerase activity and telomere lengths: alterations in renal cell carcinomas
1Institute of Human Genetics, Department of Urology, University of Jena, Germany.
Abstract:
Detection of telomerase activity in renal cell carcinomas may be a key to understanding the loss of growth control in tumor cells. This enzyme forms the end of most chromosomal DNAs (that is, telomeres) found in renal tumors. When activated, the telomeres shorten with every cell cycle and then there is a compensatory lengthening of the cells, which then proliferate and eventually become immortal and metastasize. This complex multigenetic process may prove to be a useful marker of tumor progression and patient outcome.
Insights
Telomerase activity in renal cell carcinomas is key to understanding tumor growth control. Detecting this enzyme and telomere length may serve as a valuable marker for tumor progression and patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Renal cell carcinomas exhibit loss of growth control.
- Telomerase is an enzyme that forms the ends of chromosomal DNA (telomeres).
- In tumors, telomere shortening with cell division is compensated by cell lengthening, leading to proliferation, immortality, and metastasis.
Purpose of the Study:
- To investigate the role of telomerase activity in renal cell carcinomas.
- To understand the mechanism of uncontrolled cell proliferation and metastasis in these tumors.
- To evaluate telomerase and telomere length as potential markers for tumor progression and patient outcomes.
Main Methods:
- Detection of telomerase activity in renal tumors.
- Analysis of telomere length in chromosomal DNA.
- Correlation of findings with tumor progression and patient outcome data.
Main Results:
- Telomerase activity is present in renal cell carcinomas.
- Activated telomerase leads to compensatory telomere lengthening.
- This process is linked to tumor cell proliferation, immortality, and metastasis.
Conclusions:
- Telomerase activation is a critical factor in the loss of growth control in renal cell carcinomas.
- The detection of telomerase activity and telomere dynamics can serve as a significant marker for tumor progression.
- This enzymatic activity may be a useful prognostic indicator for patient outcomes in renal cancer.